PCR Market Report Forecasts qPCR, Digital PCR and Multiplex Testing Growth, Profiling 89 Companies Including Roche and Thermo Fisher

Five-year forecasts by application, technology, product and setting, from clinical labs to point of care, as syndromic multiplex panels reshape molecular diagnostics after the pandemic.Dublin, Oct. 08 ...
Business Wire

Minute Molecular’s DASH Point-of-Care COVID-19 Rapid PCR Test Gains FDA Emergency Use Authorization

EVANSTON, Ill.--(BUSINESS WIRE)--Minute Molecular Diagnostics today announced that the U.S. Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for its rapid DASH ...
BIOENGINEER

Rapid PCR Test Delivers Joint Infection Answers in Hours Instead of Weeks

A rapid PCR-based molecular test on sonication fluid from revised joint implants delivered results within hours and showed ...

VITALiS Selects Applied BioCode as Preferred Solution Provider for Molecular Gastrointestinal Pathogen Panel Testing

VITALiS and Applied BioCode today announced an expanded collaboration to support the adoption and internalization of gastrointestinal (GI) pathogen testing in commercial and physician office ...
Medical Product Outsourcing

FDA Grants Emergency Use Authorization to Seegene for its Multiplex PCR Assay

Seegene USA Inc. has received FDA Emergency Use Authorization for the Allplex HSV1-1&2/VZV2/MPXV3 Assay, a multiplex real-time PCR test.
Nasdaq

Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.

cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...
Lab Manager

FDA-Cleared Multiplex GI PCR Test Expands Molecular Options for Gastrointestinal Pathogen Detection

The US Food and Drug Administration has cleared a new multiplex gastrointestinal PCR assay designed to streamline the detection of common diarrhea-causing pathogens from a single patient sample. The ...
BIOENGINEER

PCR Test Comparison Reveals Hidden Burden of Cattle Anaplasmosis in Venezuela

A new PCR-based study in Venezuela shows that msp5-targeting diagnostics outperform msp2 primers for detecting Anaplasma ...
FT Markets

Co-Diagnostics and ReadyGo Collaborate to Evaluate Blood-Based Molecular Testing at the Point of Need, Starting with Ebola

Blood-based testing could open new markets for the Co-Dx® PCR platform, including HIV and hepatitis B and C. Co-Diagnostics and ReadyGo target decentralized Ebola detection as th ...
streetinsider

Roche rapidly develops a PCR test for Ebola within six days as rare Bundibugyo virus drives urgent need for detection

BERLIN, June 4, 2026 /PRNewswire/ -- Roche (SIX: RO, ROP; OTCQX: RHHBY) announced today that it developed a Research Use Only (RUO) molecular PCR test, via its subsidiary TIB MOLBIOL, for use on the ...
FT Markets

Co-Diagnostics to Showcase Co-Dx PCR Platform* and MTB Test at WHX Labs Johannesburg, Highlight Ebola Assay Development

Attendees are invited to join Co-Dx at Booth # H3.L38, where the Company will showcase the Co-Dx PCR platform and the Co-Dx™ PCR MTB test*. Co-Dx's participation comes amid inte ...

Co-Diagnostics Tests ReadyGo Tech for PCR Platform

Detailed price information for Co-Diagnostics Inc (CODX-Q) from The Globe and Mail including charting and trades.